Hospital mergers drive up healthcare prices

Healthcare workers were the heroes of the COVID-19 pandemic, and hospitals took on the burden of caring for the sickest patients. However, pressures from the pandemic will undoubtedly drive health systems and hospitals to mergewith unfortunate consequences for patients, Bloomberg’s editorial board recently wrote in an opinion article.

When hospitals and health systems merge, patients can get the short end of the stick. That’s because with less competition, prices actually tend to rise after these mergers, Bloomberg attested. Hospitals account for about one-third of the U.S. medical spend, which stands around $3.8 trillion per year, according to Bloomberg.

The issue has been so hotly debated that even Congress has looked into how mergers affect healthcare prices. 

As healthcare providers merge, pricing pressures fall and prices rise. And the impact often falls on patients. 

“For competition to work as it’s supposed to, transparency on prices is crucial,” the editorial board wrote.

See the full story below:

 

Amy Baxter

Amy joined TriMed Media as a Senior Writer for HealthExec after covering home care for three years. When not writing about all things healthcare, she fulfills her lifelong dream of becoming a pirate by sailing in regattas and enjoying rum. Fun fact: she sailed 333 miles across Lake Michigan in the Chicago Yacht Club "Race to Mackinac."

Around the web

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met. 

When regulating AI-equipped medical devices, the FDA might take a page from the Department of Transportation’s playbook for overseeing AI-equipped vehicles. These run the gamut from assisting human drivers to fully taking the wheel. 

Kit Crancer, RBMA board member, speaks with Radiology Business about key legislative developments on the Hill that will affect the specialty.